<!-- Smart-width banner（保持图片原色） -->
<div style="
  max-width: 1600px;     /* 控制横幅宽度 */
  margin: 0 auto;        /* 居中 */
  height: 280px;
  background:
    url('BLOOD-AND-MARROW-STEM-CELL-TRANSPLANTATION.jpg')
    center center / cover no-repeat;
  border-radius: 10px;   /* 可选：圆角，让页面更现代 */
  margin-bottom: 20px;
">
</div>



[Home](/lab) · [Members](/lab/members) · [Research](/lab/Research) · [Publications](/lab/publications) · [Contact](/lab/contact)

We study virus-driven immune remodeling after HSCT and CAR-T and develop immunotherapies in AML to improve immune recovery and disease control.  
By integrating HSCT, CAR-T, and other immune-based strategies, we aim to advance precision treatment for hematologic malignancies.
